Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis - PubMed (original) (raw)
Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis
Jason S Soden et al. Hepatology. 2007 Aug.
Abstract
Several genetic metabolic liver diseases share the pathological features of combined steatosis and cholestasis, or steatocholestasis. The aims of this study were to develop and characterize an in vivo model for steatocholestasis and to evaluate the effects of an antioxidant treatment on liver injury, oxidative stress, and mitochondrial perturbations in this model. Obese and lean Zucker rats received intravenous (IV) injections of glycochenodeoxycholic acid (GCDC) and were killed 4 hours later. Liver enzymes were measured; the liver histology was assessed, and hepatic mitochondria were analyzed for mitochondrial lipid peroxidation. In separate experiments, rats received daily injections of subcutaneous (SQ) vitamin E before GCDC infusion. Bile acid-induced injury (serum AST and ALT and liver histology) was more severe in the obese rats than in the lean rats, characterized predominantly by extensive cell necrosis with minimal evidence of apoptosis. SQ vitamin E provided significant protection against IV GCDC-induced hepatic injury, in vitro GCDC-induced permeability transition, and cytochrome C and apoptosis-inducing factor release from isolated mitochondria.
Conclusion: Steatosis sensitizes the liver to bile acid-induced necrotic hepatocyte injury, which is responsive to vitamin E therapy.
Comment in
- Is vitamin E beneficial in chronic liver disease?
Hickman I, Macdonald G. Hickman I, et al. Hepatology. 2007 Aug;46(2):288-90. doi: 10.1002/hep.21834. Hepatology. 2007. PMID: 17661404 No abstract available.
Similar articles
- Increased susceptibility of fat-laden Zucker-rat hepatocytes to bile acid-induced oncotic necrosis: an in vitro model of steatocholestasis.
Kobak GE, Dahl R, Devereaux MW, Gumpricht E, Traber M, Doctor RB, Sokol RJ. Kobak GE, et al. J Lab Clin Med. 2005 May;145(5):247-62. doi: 10.1016/j.lab.2004.12.007. J Lab Clin Med. 2005. PMID: 15902097 - Glutathione status of isolated rat hepatocytes affects bile acid-induced cellular necrosis but not apoptosis.
Gumpricht E, Devereaux MW, Dahl RH, Sokol RJ. Gumpricht E, et al. Toxicol Appl Pharmacol. 2000 Apr 1;164(1):102-11. doi: 10.1006/taap.2000.8894. Toxicol Appl Pharmacol. 2000. PMID: 10739750 - Inhibition of bile-salt-induced hepatocyte apoptosis by the antioxidant lazaroid U83836E.
Patel T, Gores GJ. Patel T, et al. Toxicol Appl Pharmacol. 1997 Jan;142(1):116-22. doi: 10.1006/taap.1996.8031. Toxicol Appl Pharmacol. 1997. PMID: 9007040 - Beta-carotene prevents bile acid-induced cytotoxicity in the rat hepatocyte: Evidence for an antioxidant and anti-apoptotic role of beta-carotene in vitro.
Gumpricht E, Dahl R, Devereaux MW, Sokol RJ. Gumpricht E, et al. Pediatr Res. 2004 May;55(5):814-21. doi: 10.1203/01.PDR.0000117845.23762.6B. Epub 2004 Feb 5. Pediatr Res. 2004. PMID: 14764912 - "Let there be bile"--understanding hepatic injury in cholestasis.
Sokol RJ, Devereaux M, Dahl R, Gumpricht E. Sokol RJ, et al. J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S4-9. doi: 10.1097/01.mpg.0000226384.71859.16. J Pediatr Gastroenterol Nutr. 2006. PMID: 16819400 Review.
Cited by
- Current, emerging, and potential therapies for non-alcoholic steatohepatitis.
Yang Z, Wang L. Yang Z, et al. Front Pharmacol. 2023 Mar 30;14:1152042. doi: 10.3389/fphar.2023.1152042. eCollection 2023. Front Pharmacol. 2023. PMID: 37063264 Free PMC article. Review. - The Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?
Licata A, Zerbo M, Como S, Cammilleri M, Soresi M, Montalto G, Giannitrapani L. Licata A, et al. Nutrients. 2021 Nov 10;13(11):4014. doi: 10.3390/nu13114014. Nutrients. 2021. PMID: 34836267 Free PMC article. Review. - Current treatment paradigms and emerging therapies for NAFLD/NASH.
Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Raza S, et al. Front Biosci (Landmark Ed). 2021 Jan 1;26(2):206-237. doi: 10.2741/4892. Front Biosci (Landmark Ed). 2021. PMID: 33049668 Free PMC article. Review. - Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease.
Wu J, Meng QH. Wu J, et al. World J Gastroenterol. 2020 Aug 21;26(31):4567-4578. doi: 10.3748/wjg.v26.i31.4567. World J Gastroenterol. 2020. PMID: 32884217 Free PMC article. Review. - Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.
Della Pepa G, Vetrani C, Lombardi G, Bozzetto L, Annuzzi G, Rivellese AA. Della Pepa G, et al. Nutrients. 2017 Sep 26;9(10):1065. doi: 10.3390/nu9101065. Nutrients. 2017. PMID: 28954437 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical